Related by context. All words. (Click for frequent words.) 62 chlamydial infection 61 CVD mortality 61 PSADT 61 prescribed statins 61 recurrent VTE 60 albumin excretion 60 TNF antagonist 60 elevated triglyceride levels 60 HIV seroconversion 60 HBV infections 59 thyrotropin levels 59 serum creatinine levels 59 advanced adenoma 59 virologic failure 59 SLNB 59 HIV HCV coinfected 59 cervical lesions 59 APOE ε4 59 spontaneous preterm delivery 59 genital herpes infections 59 beta blocker therapy 59 neutrophil counts 59 CIN3 59 lipid lowering therapy 58 HER2 overexpression 58 neurodevelopmental impairment 58 lipid lowering medications 58 nonadherence 58 complete cytogenetic response 58 serum estradiol 58 poor metabolizers 58 psychiatric comorbidity 58 aged ≥ 58 retransplantation 58 coinfected 58 EXJADE 58 thiopurine 58 elevated ALT 58 MS relapses 58 reinfarction 58 HIV coinfected 58 elevated LDH 58 coinfection 58 subclinical hypothyroidism 57 NNRTI resistance 57 de ath 57 A1c levels 57 rebleeding 57 virological response 57 urate levels 57 hepatitis C genotype 57 postmenopausal hormones 57 polyp recurrence 57 nonfasting triglyceride levels 57 serum albumin 57 hydroxyvitamin D levels 57 pCR 57 CCyR 57 HAART 57 TDF FTC 57 genital ulcer disease 57 SHBG levels 57 suboptimal adherence 57 recurrent glioblastoma multiforme 57 immunosuppressive medications 57 serum lipid levels 57 serum testosterone levels 57 de aths 57 troponin T 57 ALT flares 57 lymphocytosis 57 HNSCC 57 antiandrogens 57 detectable HCV RNA 57 LHRH agonists 57 latent tuberculosis infection 56 serum urate levels 56 β blockers 56 antibody titer 56 undergone splenectomy 56 fragility fracture 56 EBV infection 56 serum calcium levels 56 relapsed MM 56 aminotransferase levels 56 biochemical relapse 56 KRAS mutant tumors 56 Heavy menstrual bleeding 56 postmenopausal estrogen 56 achieved sustained virological 56 severe rotavirus gastroenteritis 56 adenoma recurrence 56 virological failure 56 mutated K ras 56 basal cell nevus syndrome 56 HGPIN 56 prostate carcinogenesis 56 MMSE scores 56 hippocampal atrophy 56 renal flares 56 fetal malformations 56 subfertility 56 serum uric acid 56 BRCA2 mutations 56 hematopoietic cancers 56 tanned indoors 56 prostate cancer CaP 56 revascularization procedure 56 neurodevelopmental outcome 56 T1DM 56 thrombotic complications 56 IGFD 56 Hb A1C 56 receiving antiretroviral therapy 56 renal dysfunction 56 intravenous bisphosphonates 56 GRNOPC1 cells 56 MMSE score 56 eGFR 56 HIV uninfected 56 anovulatory infertility 56 metastatic lung cancer 56 GnRH agonists 56 peginterferon 56 hepatorenal syndrome 56 CYP#D# genotype 56 systolic dysfunction 56 methotrexate therapy 56 specific antigen PSA 56 folate concentrations 56 APTIVUS r 55 LV dysfunction 55 HbF 55 TEAEs 55 tipranavir ritonavir 55 familial AF 55 NAbs 55 nonselective NSAIDs 55 nephrotoxicity 55 transaminase levels 55 ICD implantation 55 albumin excretion rate 55 PNH patients 55 androgen deprivation 55 CMV infection 55 PSA nadir 55 ribavirin therapy 55 Chlamydia infection 55 advanced adenomas 55 NIHSS score 55 antioxidant supplementation 55 tumor histology 55 undetectable viral 55 arterial thromboembolic events 55 asymptomatic PAD 55 cTnT 55 recurrent UTI 55 HBeAg negative 55 GBM tumors 55 ICD implants 55 shortened telomeres 55 Ishak fibrosis score 55 antiretroviral naive 55 Thal Dex 55 hsCRP levels 55 beta carotene supplementation 55 corticosteroid dose 55 seropositivity 55 adverse cytogenetics 55 mL/min/#.# m 2 55 serum folate concentrations 55 squamous cell lung cancer 55 peginterferon alfa 55 nonvaccine 55 postoperative mortality 55 glucocorticoid therapy 55 EDSS scores 55 HBeAg seroconversion 55 alteplase 55 baseline HbA1c 55 colorectal liver metastases 55 multivariable adjustment 55 HER2 expression 55 lymphocyte count 55 abdominally obese 55 antiretroviral naïve 55 CHD mortality 55 prospectively stratified 55 intracranial hemorrhage ICH 55 abacavir Ziagen 55 thyrotropin 55 haemorrhagic stroke 55 androgen suppression 55 anemia hemoglobin 55 definite stent thrombosis 55 KIF6 carriers 55 neuropsychological impairments 55 nonmelanoma skin cancers 55 catheter angiography 55 colorectal adenoma 55 ADPKD 55 sustained virologic response 55 underwent liver transplantation 55 ARB telmisartan 55 multivariate adjustment 55 biochemical recurrence 55 Homocysteine levels 55 concomitant antibiotics 55 HER2 positive cancers 55 invasive fungal infection 55 seroconversion 55 palivizumab 55 coinfected patients 55 cranial irradiation 55 opioid overdose 55 COPD exacerbations 55 Suicidal ideation 55 glomerular filtration 55 Adjuvant chemotherapy 55 PASI scores 55 HCV antibody 55 colorectal neoplasia 55 BRCA1 mutation carriers 55 genital ulcers 55 symptomatic VTE 55 bronchopulmonary dysplasia 55 oral prednisolone 55 #.#ng/ml 55 serum calcium 55 metastatic RCC 55 flutamide 55 atypical ductal hyperplasia 55 leukaemias 55 serum vitamin D 55 shorter telomere length 55 euthyroid 55 operable breast cancer 54 MGUS 54 darbepoetin alpha 54 comorbid illnesses 54 platelet reactivity 54 diabetic kidney 54 dalteparin 54 HSCT 54 osteosarcomas 54 atherosclerotic progression 54 HbA1C levels 54 recurrent venous thromboembolism 54 multivariable analysis 54 canakinumab 54 imatinib therapy 54 preterm deliveries 54 prostate adenocarcinoma 54 serum phosphate 54 protease inhibitor mutations 54 ano genital warts 54 genotypic resistance 54 pg ml 54 mIU L 54 noncardiac 54 spontaneous preterm birth 54 malaria endemic regions 54 serum testosterone 54 Viral load 54 overt hypothyroidism 54 BRCA mutation carriers 54 dopaminergic therapy 54 chronic periodontitis 54 IV bisphosphonates 54 Erectile function 54 advanced neoplasia 54 immunodeficient 54 clodronate 54 creatinine levels 54 cART 54 CR nPR 54 angiographic restenosis 54 ritonavir boosted lopinavir 54 alemtuzumab treated 54 lipoatrophy 54 attain statistical significance 54 hepatocellular carcinomas 54 Decitabine 54 anthracycline therapy 54 decompensated heart failure 54 neurocognitive deficits 54 MELD scores 54 recurrent miscarriage 54 Vitamin D deficient 54 undetectable HBV DNA 54 nonresponders 54 prescribe statins 54 titrated glipizide 54 Femara letrozole 54 SHPT 54 uninfected chimps 54 GnRH agonist 54 postoperative morbidity 54 psychiatric comorbidities 54 thrombocytopenic 54 CHD CVD 54 anal HPV 54 telomere lengths 54 histologically confirmed 54 deep venous thromboses 54 Subgroup analyzes 54 SCIg 54 untreated AML 54 neurocognitive impairment 54 perioperative complications 54 APOE e4 54 rimonabant #mg 54 reperfusion therapy 54 preoperative chemotherapy 54 venous thromboembolic disease 54 ICD shocks 54 HCV infection 54 lipid elevations 54 venous blood clots 54 BRCA mutation 54 abnormal Pap smears 54 symptomatic carotid stenosis 54 HPV genotypes 54 perioperative mortality 54 CMV disease 54 plasma viremia 54 VTEs 54 bezafibrate 54 perinatal transmission 54 progesterone receptor negative 54 selenium supplementation 54 eosinophil count 54 BCG vaccinated 54 tryptase 54 β blocker 54 HAART regimen 54 autonomic dysfunction 54 T2DM 54 disease progression 54 glycated hemoglobin levels 54 testosterone supplementation 54 nondiabetic patients 54 HAART initiation 54 HAART regimens 54 WNV infections 54 R0 resection 54 initiating antiretroviral therapy 54 decompensated cirrhosis 54 IFN gamma 54 SUVmax 54 nocturnal hypoglycaemia 54 pharmacologic intervention 54 Y BOCS 54 elevated LDL cholesterol 54 HbA 1c levels 54 hip BMD 54 tumor recurrence 54 CIN2 + 54 rhTSH 54 sotalol 54 Kaplan Meier estimates 54 neurologic sequelae 54 serum urate 54 Combination antiretroviral therapy 54 bacterial prostatitis 54 serum aminotransferase levels 54 renal cell carcinomas 53 virologically 53 KRAS mutations 53 hemoglobin concentrations 53 malignant neoplasm 53 serum folate 53 distal colon cancer 53 posttransplant 53 nonvertebral fractures 53 adiponectin levels 53 plasma HCV RNA 53 untreated sleep apnea 53 cerebral vasospasm 53 HBsAg 53 microalbuminuria 53 severe periodontitis 53 serum parathyroid hormone 53 Myocardial infarction 53 unexplained stillbirth 53 myocardial infarctions MIs 53 nonvertebral fracture 53 #OHD levels 53 type 1diabetes 53 elevated transaminases 53 liver transplant recipients 53 serum LDL cholesterol 53 Calcium intake 53 achieved CCyR 53 endometrial cancers 53 achieve sustained virologic 53 HBV infection 53 venous thromboembolic events 53 androgen deficiency 53 fragility fractures 53 BEXXAR Therapeutic Regimen 53 darunavir r 53 abnormal mammograms 53 estrogen hormone therapy 53 sustained virological response 53 evaluable subjects 53 log# reduction 53 carotid plaque 53 bilateral oophorectomy 53 anti HBs 53 curative resection 53 perioperatively 53 low dose Iluvien 53 rtPA 53 Kaplan Meier analysis 53 aminotransferases 53 infectious syphilis 53 adnexal mass 53 Postoperative complications 53 neutropenic patients 53 onset diabetes mellitus 53 alanine aminotransferase ALT 53 salivary flow 53 chronic HBV 53 testicular germ cell 53 viremic 53 beta adrenergic receptor 53 nonischemic cardiomyopathy 53 elevated bilirubin 53 Cognitive impairment 53 parasitaemia 53 anagrelide 53 leukemic transformation 53 rFVIIa 53 K ras mutations 53 thrombotic events 53 Velcade bortezomib 53 postintervention 53 atrophic gastritis 53 distant metastases 53 VaD 53 HBeAg 53 nonmelanoma 53 ejection fractions 53 serum HCV RNA 53 postoperative infection 53 antiviral therapy 53 shorter telomeres 53 immunosuppression therapy 53 CDI recurrence 53 weekly subcutaneous injections 53 untreated OSA 53 fosamprenavir 53 smoldering multiple myeloma 53 HOMA IR 53 estimated GFR 53 serum ALT 53 severe hypoglycaemia 53 unruptured aneurysm 53 postoperative atrial fibrillation 53 recurrent ischemia 53 antiretroviral therapy 53 abacavir lamivudine 53 lamivudine refractory patients 53 elevated homocysteine 53 taxane therapy 53 seroconverted 53 carotid IMT 53 opioid dependent 53 noncardiovascular mortality 53 revaccination 53 bronchopulmonary dysplasia BPD 53 angiotensin receptor blockers ARBs 53 abnormal lipid 53 antihypertensive therapy 53 SIV infection 53 elevated depressive symptoms 53 HIV seronegative 53 nonfatal MI 53 locoregional recurrence 53 intensive statin therapy 53 invasive ductal breast cancer 53 homocysteine concentrations 53 undergoing bariatric surgery 53 Arch Intern Med 53 neoadjuvant chemotherapy 53 Unintended pregnancies 53 triglyceride concentrations 53 metastatic kidney 53 prognostic variables 53 underwent CABG 53 hepatic toxicity 53 NATRECOR ® 53 neurocognitive function 53 immuno suppression 53 pneumococcal infection 53 revascularizations 53 certolizumab 53 paclitaxel eluting stents 53 familial aggregation 53 postoperative delirium 53 undetectable viral loads 53 prevalences 53 #ng/ml 53 glomerular filtration rate 53 Retreatment 53 inecalcitol 53 hepatoma 53 hematological parameters 53 subclinical disease 53 serum clusterin levels 53 HbA1C 53 rindopepimut 53 amenorrhoea 53 chronic hepatitis cirrhosis 53 CsA 53 FLT3 mutations 53 BLLs 53 lactate dehydrogenase LDH 53 subclinical hyperthyroidism 53 testicular tumors 53 periprocedural MI 53 PIGF 53 hypovitaminosis D 53 postoperative pulmonary 53 Reverset 53 noncancer 53 ovulatory cycles 53 HBV DNA levels 53 prescribed antipsychotics 53 ABCB1 53 CP CPPS 53 socioeconomic status SES 53 serum IgE 53 poorer prognosis 53 glycated hemoglobin HbA1c 53 proliferative retinopathy 53 creatinine ratio 53 pharmacokinetic interactions 53 postexposure prophylaxis 53 morphometric vertebral fractures 53 divalproex sodium 53 rhGH 53 FASLODEX 53 severe exacerbations 53 bladder carcinoma 53 DAS# remission 53 genital HPV infections 53 #q# deletion syndrome 53 WNV encephalitis 53 recurrent myocardial infarction 53 bacteriuria 53 bioavailable testosterone 53 lobular cancer 53 antipsychotic prescribing 53 born preterm 53 differentiated thyroid 53 chromium supplementation 53 virologic response 53 Chlamydia trachomatis infection 53 gallstone disease 53 plasma folate 53 rectal gonorrhea 53 symptomatic intracranial hemorrhage 53 PCNSL 53 immunosuppressive regimens 52 mammographic density 52 cytomegalovirus infection 52 osteoporotic fractures 52 underwent surgical resection 52 ng dL 52 immunosuppressive therapies 52 chlamydial infections 52 immune reconstitution syndrome 52 atheroma volume 52 erlotinib Tarceva 52 NRTI backbone 52 transgenic rats 52 severe renal impairment 52 immunosuppressant therapy 52 receiving VICTRELIS 52 Scale EDSS score 52 parous women 52 adjuvant tamoxifen 52 GIST tumors 52 psychiatric morbidity 52 underactive thyroids 52 lumbar spine BMD 52 microscopic hematuria 52 SRBD 52 de novo AML 52 AGILECT R 52 tibolone 52 inhospital 52 antimicrobial prophylaxis 52 foveal thickness 52 underwent coronary angiography 52 KRAS status 52 octreotide LAR 52 BRCA2 mutation carriers 52 lowering homocysteine 52 endometrial hyperplasia 52 bilirubin levels 52 platelet activation 52 P. falciparum malaria 52 GBA mutations 52 chronic HBV infection 52 plasma pharmacokinetics 52 thromboembolic complications 52 PLCO 52 undetectable viral load 52 elevated CRP 52 superinfection 52 postoperative complication 52 MRSA colonization 52 hypoglycaemic episodes 52 combination antiretroviral therapy 52 ertapenem 52 IGFBP 52 Zevalin consolidation 52 vaccinees 52 Genetic variants 52 apolipoprotein E4 52 hydroxyvitamin D concentrations 52 HBeAg negative patients 52 hormone refractory 52 autoimmune thyroid 52 neurodevelopmental outcomes 52 Abacavir 52 oropharyngeal cancer 52 obstructive coronary artery 52 mRCC 52 subclinical atherosclerosis 52 DAS# scores 52 prostate abnormalities 52 adenomatous polyps 52 distant metastasis 52 Tumor shrinkage 52 undergoing coronary angiography 52 hematologic toxicity 52 hepatectomy 52 VT VF 52 liver metastasis 52 axillary node 52 multivariable adjusted 52 nonsevere 52 NATRECOR R 52 estimated glomerular filtration 52 intima media thickness 52 PLX STROKE targeting 52 ECD kidneys 52 carotid stenosis 52 histologic subtype 52 EDARBI 52 placental malaria 52 IPAH 52 KRAS mutations occur 52 gestational diabetes mellitus GDM 52 non squamous NSCLC 52 WNV infection 52 interstitial pneumonia 52 antiangiogenic therapy 52 hypoglycemic episodes 52 androgen ablation 52 nonadherent 52 HAV infection 52 transfusion transmitted 52 ancrod 52 statins cholesterol lowering 52 amisulpride 52 riociguat 52 nephrotoxic drugs 52 response CCyR 52 mg kg dose 52 DHEA supplementation 52 resected pancreatic cancer 52 gemifloxacin 52 postmenopausal hormone 52 asymptomatic carotid stenosis 52 seroprotection 52 folate deficient 52 serodiscordant couples 52 BRIM3 52 cardiovascular hospitalizations 52 HCV genotype 52 surrogate endpoint 52 Mylotarg 52 APTIVUS ritonavir 52 goserelin 52 prospectively defined 52 symptomatic hyponatremia 52 reduce serum phosphate 52 meta regression 52 highest quintile 52 paricalcitol 52 graft dysfunction 52 dacarbazine chemotherapy 52 PTLD 52 HbA1c levels 52 diffuse gastric 52 transferrin saturation 52 PPSV# 52 chorioamnionitis 52 serum HBV DNA 52 achieved ACR# 52 upper gastrointestinal bleeding 52 external genital lesions 52 estrogen progestin therapy 52 noncarriers 52 SCr 52 imatinib resistance 52 precancerous cervical lesions 52 serum sodium levels 52 vertebral fracture 52 serum BDNF 52 mepolizumab 52 sUA 52 IGFBP 3 52 nondepressed 52 nutlin 3a 52 thromboembolic disease 52 nondiabetics 52 potent antiretroviral therapy 52 H. pylori infections 52 maximal doses 52 postprocedure 52 T1c 52 ATACAND 52 decompensated liver disease 52 cTnT levels 52 Heterozygous Familial Hypercholesterolemia 52 tHcy 52 mycophenolate mofetil 52 lymphocyte counts 52 viral kinetics 52 TT genotype 52 renal scarring 52 dose statin therapy 52 lipid lowering drugs 52 renal toxicity 52 ritonavir boosted protease inhibitor 52 serum homocysteine 52 sero positive 52 heavily pretreated 52 antiandrogen 52 antiretroviral ARV therapy 52 retrospective cohort 52 BYSTOLIC 52 TMP SMX 52 lenalidomide Revlimid R 52 genital ulcer 52 #mg ATC 52 PROSTVAC VF 52 drank decaffeinated coffee 52 gestational hypertension 52 Celiac disease affects 52 invasive carcinoma 52 prescribing statins 52 STRIDE PD 52 QTc intervals 52 undergo radical prostatectomy 52 BRAF mutation 52 orchitis 52 leukocyte count 52 seropositive patients 52 paraprotein 52 LTBI 52 pT3 52 minimally symptomatic 52 BENICAR HCT 52 plasma homocysteine levels 52 missense mutations 52 recurrent wheezing 52 fluvastatin 52 herpes zoster vaccine 52 del 5q MDS 52 HCV RESPOND 2 52 typical antipsychotics 52 Telomere length 52 BRCA mutations 52 extracolonic findings 52 PCPT 52 statin medications 52 CD4s 52 arterial calcification 52 EGFR mutation positive 52 Circumcised men 52 chronic GVHD 52 perinatal morbidity 52 prolonged QT interval 52 PlGF 52 cardiovascular mortality 52 latent TB infection 52 CC genotype 52 lung metastasis 52 efalizumab 52 Skin sterol 52 underdiagnosis 52 receiving immunosuppressive therapy 52 baseline serum creatinine 52 symptomatic intracerebral hemorrhage 52 abnormal pap smear 52 PROactive study 52 d4T 52 univariate analyzes 52 serum PSA 52 curative therapy 52 nmol L. 52 atypical antipsychotic medications 52 BRCA1 mutations 52 BCIRG 52 hormonally sensitive 52 Prostate specific antigen 52 oxcarbazepine 52 recurrent tonsillitis 52 moderate renal impairment 52 liver histology 52 clinically insignificant 52 low birthweight infants 52 REYATAZ r arm 51 Avandia Actos 51 macroalbuminuria 51 Stent thrombosis 51 Chronic ITP 51 glycosylated hemoglobin HbA1c 51 baseline LDH 51 serous ovarian cancer 51 iniparib BSI 51 silent ischemia 51 chlamydia infection 51 pancreatic adenocarcinoma 51 nonnucleoside reverse transcriptase inhibitors 51 EDSS score 51 unstable angina pectoris 51 CD4 counts 51 nonmelanoma skin cancer 51 null responders 51 bacteraemia 51 seronegative 51 warfarin therapy 51 prior chemotherapy regimens 51 lactate dehydrogenase 51 urinary albumin excretion 51 neonatal morbidity 51 variceal bleeding 51 virological suppression 51 isolated systolic hypertension 51 baseline serum bilirubin 51 intraventricular hemorrhage 51 cervical intraepithelial neoplasia 51 adrenal function 51 hemoglobin A1c levels 51 adrenal suppression 51 MetS 51 HYVET 51 plasma homocysteine 51 IV tPA 51 blastic phase 51 uridine triacetate 51 Statin therapy 51 limiting generalizability 51 tuberculin skin testing 51 Uncontrolled hypertension 51 clinically evaluable patients 51 hepatitis B immunoglobulin 51 ddI 51 parasitemia 51 airway responsiveness 51 Tysabri infusions 51 IgA deficiency 51 hypercholesterolaemia 51 decitabine 51 COREG 51 de novo mutations 51 acute GVHD 51 Hgb 51 hypercalcemia 51 weekly intravenous infusions 51 overt hepatic encephalopathy HE 51 thiazides 51 F FDG PET 51 fetal chromosomal 51 conjugated equine estrogen 51 phytoestrogen intake 51 nulliparous women 51 hyperprolactinemia 51 systemic toxicity 51 oral antidiabetic medication 51 ipsilateral stroke 51 HPV subtypes 51 finasteride Proscar 51 cystectomy 51 adalimumab Humira 51 perioperative morbidity 51 acute myocardial infarction MI 51 thiazide diuretics 51 acquired immunodeficiency syndrome 51 vitamin D inadequacy 51 hemorrhagic strokes 51 cotrimoxazole prophylaxis 51 periodically reassessed 51 MELD score 51 neurologic complications 51 hepatotoxicity 51 Fibrillex TM 51 pretest probability 51 mutated KRAS 51 hereditary predisposition 51 familial clustering 51 MADIT II 51 DFMO 51 Renal Cell Carcinoma RCC 51 BARACLUDE ® 51 splenectomized patients 51 Antiretroviral therapy 51 complete cytogenetic 51 prednisone prednisolone 51 olmesartan 51 ovarian hyperstimulation syndrome OHSS 51 HBV DNA 51 suicide ideation 51 abnormal Pap smear 51 lipohypertrophy 51 neutropenic fever 51 % CI #.#-#.# [007] 51 cranial radiation 51 perinatal complications 51 tarenflurbil 51 #mg dose [002] 51 testosterone secretion 51 System IPSS 51 affective psychoses 51 recurrent ischemic stroke 51 GSTT1 51 estrogen receptor negative 51 progression TTP 51 CD4 lymphocyte count 51 serum IGF 51 CHD coronary 51 Kinoid 51 nucleotide analog 51 precancerous tumors 51 Aß 51 radioiodine therapy 51 anthracycline taxane 51 renal transplants 51 trivalent inactivated influenza 51 folate intake 51 nonmetastatic 51 ventricular tachyarrhythmia 51 premenstrual syndrome PMS 51 PSVT 51 lymphatic cancers 51 PCA3 scores 51 cholinergic tone 51 oesophageal adenocarcinoma 51 mg/m2 dose 51 CK # plasma concentrations 51 GSTM1 gene 51 gestational diabetes mellitus 51 atypical fractures 51 Telintra 51 prospectively enrolled 51 Subgroup analysis 51 antigen PSA levels 51 C. trachomatis 51 elevated hsCRP 51 antigen PSA 51 ALT elevation 51 pathologic fractures 51 HCV infections 51 invasive aspergillosis 51 chlamydia infections 51 HIV seroprevalence 51 ALT normalization 51 coronary calcification 51 inhaled glucocorticoids 51 adjuvant therapies 51 ofpatients 51 hyperglycaemia 51 cortisol concentrations 51 Cytogenetic 51 colorectal neoplasms 51 HCV infected 51 bone metastasis 51 TroVax ® 51 idraparinux 51 EGRIFTA TM tesamorelin 51 pre eclamptic 51 IFN alfa 51 ASCUS 51 Colorectal cancer incidence 51 blood glucose concentrations 51 liver scarring 51 everolimus eluting stents 51 colorectal carcinomas 51 somatostatin analogs 51 NHANES III 51 untreated celiac disease